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R E S E A R C H
Massage Impact on Pain in 
Opioid-dependent Patients in 
Substance Use Treatment
Background: Chronic pain is a common cause 
of health care utilization and high levels of pain 
are pronounced in individuals engaged in metha-
done maintenance treatment. Although massage 
has been demonstrated to alleviate chronic pain 
symptoms, its use as an adjunctive therapy to 
modify pain during opioid-replacement treatment 
is absent from the literature.
Purpose: To consider the efficacy of Swedish mas-
sage in reducing pain in opioid-dependent patients 
with chronic pain receiving methadone treatment. 
Setting: Trial was conducted at a nonprofit metha-
done treatment center serving low-income patients. 
Research Design: A randomized clinical trial 
with randomized to either 1) massage plus treat-
ment-as-usual (TAU) (n = 27) or 2) TAU (n = 24). 
Durability of treatment effect was evaluated at 
Week 12.
Intervention: Eight weekly 50-minute Swedish 
massage sessions plus TAU or TAU alone.
Main Outcome Measures: Pain, anxiety, depres-
sion, physical functioning, decreased substance 
use, and improvement in treatment engagement. 
Results: Randomized participants were compa-
rable at Baseline for demographic, pain, physical, 
and emotional variables. Massage group reported 
improved pain scores; worst pain had a clinically 
significant 2-point improvement while the other 
pain scores did not. Overall improvements were 
not observed in treatment engagement or levels 
of anxiety, depression, or physical functioning. A 
subgroup of the participants, who felt they could 
be pain-free, consistently reported improvements 
in pain from Baseline to Week 8, and this was 
most pronounced and clinically significant in the 
massage group. 
Conclusions: These preliminary findings do not 
support an overall clinically significant positive 
effect of Swedish massage on reduction in pain 
ratings or improvement in anxiety, depression, 
or treatment engagement in a substance-using, 
opioid-dependent population with chronic pain. 
Future nonpharmacologic pain research in mar-
ginalized substance-using populations may wish 
to consider some of the challenges and limitations 
faced in this project.
KEY WORDS: massage; pain; opioid dependence; 
substance use; self-efficacy; methadone
introduCtion 
Chronic pain is a common cause of health care 
utilization and represents a major health concern.
(1) The overlap of chronic pain and substance use 
has been recognized since early in the twentieth 
century(2) and has been examined extensively with a 
focus on chronic pain in patients engaged in care.(3-14) 
Relatively high self-reports of pain are of particular 
concern within substance-use treatment populations, 
and are most pronounced for individuals engaged in 
methadone maintenance treatment.(4,15-17) Estimates 
of chronic pain in opioid-dependent patients receiv-
ing methadone ranges from 37% to 80%.(4) In sharp 
contrast, the estimated chronic pain prevalence in the 
general population ranges from 11%(18) to 30.7%.(1) 
Since the 1960s, methadone has been used suc-
cessfully for treatment of opioid dependence.(19) For 
patients with chronic pain prior to starting methadone 
treatment, over half reported that their pain predated 
their addiction(20) and 44% identified pain as their 
reason for enrolling in methadone treatment rather 
than other opioid-dependence treatment options.(16) 
Chronic pain patients had more extensive addiction 
treatment histories, more severe opioid cravings, 
earlier age at first opioid use, and more psychiatric 
and health concerns.(13) Individuals with dependence 
on opioid analgesics reported higher levels of chronic 
pain(16) and stated that their pain contributed to their 
addiction.(3) Patients with chronic pain had higher 
average daily methadone doses,(6) more severe pat-
terns of polysubstance use, and more medical and 
social problems.(7) Chronic pain was associated with 
negative treatment outcomes, such as medical and 
psychiatric comorbidity and counselor frustration.
(9) In this population, nonpharmacologic options for 
chronic pain management are limited.
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treatment, remain in methadone therapy for the study 
duration, and provide informed consent. Exclusion-
ary conditions, determined by the medical staff in 
conjunction with the lead licensed massage therapist 
(LMT), included: pregnancy; pending incarceration; 
severe and persistent mental health concerns;(29) bro-
ken bones, fractures, dislocations, or severe sprains; 
open or unhealed sores or wounds such as injection site 
abscesses; body areas persistently inflamed, swollen or 
bruised; recent surgery (within past eight weeks); se-
vere incapacitating pain requiring immediate medical 
attention; hemorrhaging or active bleeding; or chronic 
severe high blood pressure or heart problems (defined 
as > 160/90). The 90-day time interval was an indicator 
of patient commitment to recovery and engagement 
in treatment, as over 34% of patients initiating care 
at this clinical site withdraw within the first 90 days. 
Participant selection
All new patients received a physical exam which 
included chronic pain assessment conducted by a 
medical clinician prior to induction on methadone. 
Results were recorded in their electronic medical 
record (EMR). Between 5/1/2011 and 2/29/2012, 
211 nonduplicated new patients initiated medication-
assisted treatment for opioid dependence at the treat-
ment agency. Of these, 78% completed intake (n = 
165) and 65% (n = 137) remained in treatment for 
a minimum of 90 days. Of patients in treatment for 
≥ 90 days, 80 (58%) reported chronic pain lasting at 
least six months of ≥ 4 on an NRS. A minimum of 
three attempts were made to contact all 80 patients 
to invite them to a study screening visit, at which 
time eligibility was confirmed. Out of concern that a 
participant might withdraw if they were not random-
ized to their preferred treatment regime, Baseline data 
were collected prior to randomization.
randomization
After participants completed the Baseline assess-
ments, a research associate called an agency branch 
not affiliated with the research department and group 
assignments were made based on a random number 
generator to TAU or massage plus TAU.
Measures
Pain measures and other assessments used were 
designed to mirror the domains recommended by 
Initiative on Methods, Measurement, and Pain As-
sessment in Clinical Trials (IMMPACT)(30) for use 
in clinical trials of chronic pain. Instruments used to 
assess the following domains: 1) pain intensity by 
The Numeric Rating Scale (NRS)(28) – NRS measures 
pain on a 0 (no pain) to 10 (worst pain imaginable) 
scale, including pain in the last 24 hours, average 
daily pain, and worst pain; 2) emotional functioning 
through the Hospital Anxiety and Depression Scale 
The term “massage therapy” encompasses many 
different touch therapy techniques. Swedish mas-
sage is the most widely studied and reported mas-
sage technique in the literature.(21) Swedish massage 
incorporates moderate pressure touching(22) and has 
minimal risk of adverse events, making it appropriate 
for protocol standardization and comparisons across 
studies. Using a standardized Swedish massage 
protocol, clinical research in healthy adults found a 
cumulative positive biologic effect which varied with 
massage frequency.(22,23) While the precise biologic 
mechanism through which massage effects pain is 
unclear,(24) consistent support exists for the beneficial 
effects for treating chronic pain, especially chronic 
low-back pain.(21) A 2007 review of clinical trials 
found massage was superior to relaxation therapy, 
acupuncture, and self-help education.(21,25) Comple-
mentary and Alternative Medicine (CAM) therapies 
are viewed as highly effective in substance-use 
treatment populations(26) and specifically in opioid-
dependent patients.(9) 
Randomized controlled trial research on use 
of massage as an adjunctive therapy to modify 
pain during opioid-replacement treatment is lack-
ing. The goal of this pilot project was to begin to 
initiate consideration of massage’s potential as an 
adjunctive nonpharmacologic pain treatment in 
substance-using, opioid-dependent patients receiv-
ing methadone maintenance.
Methods
design
In this 12-week randomized clinical trial (RCT), 
participants were assigned to either an intervention 
arm of eight weekly 50-minute Swedish massage 
sessions and treatment-as-usual (TAU) (n = 27) or 
to TAU alone (n = 24), with a follow-up visit four 
weeks after completing the intervention. Sample 
size was determined by minimum number needed to 
detect a 20% difference between groups. The study 
was approved by a local academic institutional review 
board and participants provided written informed 
consent. Participants randomized to the massage arm 
completed an additional massage informed consent.
study population
Study participants were recruited from a large, 
nonprofit medication-assisted treatment program for 
opioid dependence. Eligibility criteria required that 
participants be age 18 or older, meet DSM-IV-TR(27) 
criteria for opioid dependence, receive methadone 
treatment for opioid dependence for at least 90 days, 
report nonneuropathic chronic pain at intake of inten-
sity ≥ 4 on a 0 to 10 numeric rating scale (NRS),(28) 
be willing to forgo any nonstudy-related massage 
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hosted at CODA, Inc.(41) REDCap is a secure, web-
based application designed to support data capture for 
research studies, providing: 1) an intuitive interface 
for validated data entry; 2) audit trails for tracking 
data manipulation and export procedures; 3) auto-
mated export procedures for seamless data downloads 
to common statistical packages; and 4) procedures for 
importing data from external sources.(41)
treatment-as-usual (tAu)
All participants, regardless of randomization 
group, continued to receive their usual care including 
daily methadone dosing, weekly random urine drug-
screen testing, at least one weekly group session, and 
monthly individual counseling sessions. 
swedish Massage therapy
The massage protocol (Appendix A) was designed 
by an LMT instructor at a local accredited LMT 
school with 12 years of experience. The protocol was 
a tightly scripted 50-minute session, conducted once a 
week for the first eight weeks of the study. Individual 
sessions were conducted on massage tables in private 
rooms. The number of sessions was based on recom-
mendations from the massage consultant and to be 
consistent with the literature.(21) To maintain fidelity, 
selected sessions were observed, timed, and reviewed 
by the lead LMT. 
licensed Massage therapists (lMt) 
The study interventions were conducted by one of 
four LMTs, all of whom were licensed in the state of 
Oregon. All LMTs had bachelor degrees prior to at-
tending LMT schools, expressed interest in research, 
had experience with marginalized populations, and 
were willing to be trained to and follow a standard-
ized Swedish massage protocol. LMTs were not as-
signed to a specific participant. This approach was 
to minimize potential bias introduced by a relation-
ship between the LMT and participant rather than 
from a positive massage effect. Given the number 
of participants who had previously exchanged sex 
for goods or services, male LMTs treated males and 
female LMTs treated females. Issues or concerns 
regarding gender orientation were not raised in the 
course of the trial.
schedule of data Collection 
Data were collected by trained research associates. 
Given the nature of the design, it was not possible to 
blind staff to group assignment. Data were collected 
prior to massage intervention, as the goal was to as-
sess how the participants felt on average during the 
previous week. Data and survey instrument collection 
varied by the visit week (Table 1) and instrument 
(HADS)(31) – HADS clusters participants by anxiety 
and depression with scores of 0–7 (not depressed/anx-
ious), 8–10 (suggestive), and 11+ (anxious/depressed) 
on a 0–21 scale; 3) improvement and satisfaction 
with treatment through the Patient Global Impression 
of Change (PGIC)(32,33) – PGIC measures patient-
reported improvement or deterioration over time on 
a 7-point scale (very much worse to very much im-
proved), and at Baseline visit this score is relative to 
how participants feel compared to the last month, and 
during the study each measurement is relative to the 
last visit; 4) symptoms and adverse events through the 
TimeLine Follow-back (TLFB);(34) and 5) substance 
use and treatment engagement and retention from 
data abstracted from participants’ electronic medical 
record. For questionnaires not in the public domain, 
investigators received permission for use.
Additional data elements 
Demographics, vitals, urine drug-screen results, 
average weekly methadone doses, and substance use 
management history were abstracted from the EMR. 
Nutritional risk assessment was determined by the 
screening tool, “Determine your Nutritional Health”.
(35) Weight and blood pressure were collected at Base-
line and Weeks 4, 8, and 12. Body Mass Index (BMI) 
determined from height and weight was included, 
based on previous reports between chronic pain and 
obesity (BMI ≥ 30),(36) as well as correlation between 
methadone treatment and weight gain.(37) 
pain-free Variable
Prior to study launch, research staff and LMTs 
discussed whether the participants would report 
improvements in pain levels after massage or if they 
believed pain was such an integral part of their iden-
tity that to report improvement would be to lose a 
sense of self. Because pain is subjective and there are 
many ways it can be conceptualized,(38) participants 
were asked whether they believed they could ever 
be pain-free and what would it take to be pain-free. 
This variable is referred to as “pain-free.” Addition-
ally, participants’ chronic pain treatment history was 
documented. The constructs of self-actualization and 
self-efficacy (i.e., a person’s belief that they can per-
form a behavior(39)) may influence pain management 
and treatment outcomes.(40) There is documentation of 
this construct, linking self-efficacy, coping strategies, 
and chronic pain management.(40) This information 
was collected from participants to assess if there is 
a relationship between ability to be pain-free/self-
efficacy and changes in primary outcome measures. 
data Management
Data were managed using REDCap (Research 
Electronic Data Capture) electronic data capture tools 
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statistical Analysis
From REDCap, data were imported into STATA 
12(42) and SAS 9.2.(43) Descriptive statistics were 
computed for all study variables. Crude differences 
between massage and TAU groups were assessed 
using t tests for continuous measures and chi-square 
tests when categorical. Baseline health status measures 
were also compared between each group to identify 
any differences prior to intervention. The analysis of 
treatment effect on pain measured by the NRS pain 
scale used the data collected at Baseline, Weeks 4, 
8, and 12. Clinically significant differences in NRS 
pain measures were based on published recommen-
dations(44,45) and were defined a priori as a 2-point 
change. Comparing the percent of responders (percent-
ages of participants that meet a threshold of percentage 
decrease in pain) was used to measure the differences 
between NRS pain scores of two groups.(46) Differ-
ences between the treatment groups’ PGIC scores were 
tested using the Mann-Whitney U test for Baseline 
and Weeks 4, 8, and 12. Given the small number of 
very much worse responses (n = 3) on the PGIC, this 
category was grouped with the much worse category.
results 
study population
Of the identified target population of 80 patients, 18 
(23%) had exclusionary conditions, the most common 
of which were medical (56%) and currently pregnant 
(33%). Of the remaining 62 patients, 3 (5%) refused 
and 7 (11%) never responded to three recruitment con-
tact efforts. We enrolled 52 (84%) of eligible patients; 
however, one massage participant withdrew consent 
prior to Week 1 because of the inconvenience of keep-
ing a scheduled massage appointment (Appendix B).
Baseline Characteristics
For enrolled participants, heroin was the most-
reported drug at intake (88%) and injection drug use 
was the primary route of use (67%). The majority of 
study participants were female (53%), with a mean 
age of 40 years, currently homeless (55%), unem-
ployed (84%), at high nutritional risk (63%), and had 
been incarcerated at least once (78%). For both mas-
sage and TAU, participants’ average daily pain was 
5.8 on a 0–10 NRS scale, with an average duration 
of 12.2 years with chronic pain. Massage and TAU 
groups did not differ on demographic characteristics 
at Baseline (Table 2).
Baseline Chronic pain
Approximately three quarters (78%) of participants 
reported their chronic pain was the sequela of some 
instructions (i.e., some assessments were appropriate 
for weekly administration, others monthly, etc.). 
Visits at Baseline, Weeks 4, 8, and 12 were longer 
in duration. Baseline assessments were repeated at 
Weeks 4, 8, and 12. Progress notes completed by 
the research associates and LMTs after each study 
session provided a narrative record of the visit. All 
assessments were repeated at Week 12 to evaluate the 
durability of massage effect.
incentives
All participants received a $20 gift card to a local 
retail supermarket chain for each completed visit. 
Cash incentives were not used, given the concern that 
cash might trigger drug-seeking behaviors.
Table 1. Participant Baseline Characteristics
Characteristic Massage
(n = 27, 
53%)
TAU
(n = 24, 
47%)
Total
(N = 51)
Mean (SD) Mean (SD) Mean (SD)
Age (years) 40 (13.5) 39 (10.5) 40 (12.1)
NRS pain scores (0–10)
Last 24 hours
Average Daily
Worst Pain
5.4 (1.9)
5.8 (1.7)
8.1 (1.5)
5.8 (2.2)
5.8 (1.9)
8.0 (1.3)
5.6 (2.1)
5.7 (1.8)
8.1 (1.4)
Years with Chronic Pain 12.6 (11.8) 11.8 (7.8) 12.2 (7.7)
HADS (0 - 21 scale) 
Anxiety
Depression
10.3 (4.4)
6.6 (3.8)
11.6 (3.6)
8.0 (4.0)
10.9 (4.1)
7.5 (4.0)
n (%) n (%) n (%)
White 18 (67) 21 (88) 39 (76)
Gender
Male
Female
13
14
(48)
(52)
11
13
(46)
(54)
24
27
(47)
(53)
Obesity (BMI ≥30) 7 (26) 11 (46) 18 (35)
High Nutritional Riska 17 (71) 15 (56) 32 (63)
Belief can be pain-free 8 (29) 7 (30) 15 (29)
Socioeconomic factors
Unemployed
Ever homeless
Currently homeless
Ever incarcerated 
Never married
23
23
16
23
13
(85)
(85)
(59)
(85)
(48)
20
20
12
17
10
(83)
(74)
(46)
(71)
(42)
43
43
28
40
23
(84)
(84)
(55)
(78)
(45)
Opioid-use factors
Injection drug user
Heroin user
20
26
(74)
(96)
14
19
(58)
(79)
34
45
(67)
(88)
Polysubstance use 19 (70) 15 (63) 34 (67)
aHigh Nutritional Risk as determined by the screening tool, 
“Determine your Nutritional Heath”(32)
NRS = Numeric Rating Scale(27); HADS = Hospital Anxiety 
and Depression Scale(29). 
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Table 2. Previous Pain Treatments Ever Tried by Study Participants
Type of Treatment Ever Tried How Helpful was Treatment, n (% of Ever Tried)
n (% total) Not at all A little Somewhat Quite a Bit Very Much
1. Medication – Prescribed, Over-the-Counter, and Illicit
Prescription Opioids 
Obtained from:
Medical Clinician 
Friend, family, or dealer
Pain management clinic
ER/Urgent Care
42 (82)
47 (92)
44 (86)
37 (73)
2 (5)
1 (2)
1 (14)
2 (5)
2 (5)
3 (6)
0 
4 (11)
12 (29)
10 (21)
0
11 (30)
12 (29)
19 (40)
4 (57)
10 (27)
14 (33)
14 (30)
2 (29)
10 (27)
Prescription Benzodiazepine (Benzo)
Obtained from:
Medical Clinician
Friend, family, or dealer
5 (10)
24 (47)
0
3 (13)
1 (20)
3 (13)
2 (40)
5 (21)
2 (40)
8 (33)
0
5 (21)
Prescription Nonopioid, Non-Benzo
Obtained from:
Medical Clinician
Friend, family, or dealer
24 (47)
16 (31)
9 (38)
2 (13)
3 (13)
4 (25)
8 (33)
4 (25)
2 (8)
5 (31)
2 (8)
1 (6)
OTC Pain Reliever 51 (100) 7 (14) 14 (27) 21 (41) 6 (12) 3 (6)
Heroin 42 (82) 0 1 (2) 2 (5) 18 (43) 21 (50)
Marijuana 24 (47) 2(8) 0 8 (33) 8 (33) 5 (25)
2. Complementary and Alternative Medicine Treatments
Acupuncture 20 (39) 5 (25) 3 (15) 4 (20) 4 (20) 4 (20)
Mind-body Interventions
Prayer 
Counseling
Meditation
Self-Help Support-Group
Yoga
Hypnosis
28 (55)
12 (24)
22 (43)
3 (6)
8 (16)
2 (4)
8 (29)
4(33)
4 (33)
0
4 (50)
1 (50)
7 (25)
2(17)
2 (17)
1(33)
0
0
7 (25)
3(25)
3 (25)
0
3 (38)
0
2 (7)
2(17)
2 (17)
2 (67)
1 (12)
1 (50)
4 (14)
1(8)
1(8)
0
0
0
Herbs/Herbal Medicine 13 (25) 3 (23) 3 (23) 4 (31) 2 (15) 1 (8)
Manipulative Therapies
Stretching
Physical Exercise
Heat Therapy
Massage
Physical Therapy
Ice Therapy
Chiropractic Treatment
38 (75)
27 (53)
12 (24)
20 (39)
20 (39)
2 (4)
21 (41)
5 (13)
6 (22)
0
0
3 (15)
0
7 (33)
11 (29)
6 (22)
2 (17)
0
3 (15)
0
1 (5)
16 (42)
4 (15)
6 (50)
7 (35)
5 (25)
2 (100)
5 (24)
4 (11)
11 (41)
1 (8)
7 (35)
7 (35)
0
5 (24)
2 (5)
0
3 (25)
6 (30)
2 (10)
0
3 (14)
OTC = over-the-counter.
type of injury sustained from: a) car/motorcycle ac-
cidents (n = 12, 23%); b) sports injuries (n = 10, 19%); 
c) work-related injuries (n = 9, 18%); d) falls/accidents 
(n = 6, 12%); or e) partner abuse (n = 3, 6%). The 
remaining causes were from other medical conditions 
(i.e., headaches, back pain (n = 6, 12%); pregnancy 
(n = 3, 6%); or unknown cause (n = 2, 4%)). Previous 
to study participation, almost all (90%) of partici-
pants felt their chronic pain had worsened over time. 
A majority (57%) reported weight gain since their 
pain began. Few participants (10%) reported seeking 
treatment for their pain outside of the substance-use 
treatment facility. A majority of participants (55%) 
reported that their chronic pain was part of the reason 
they sought methadone maintenance versus other 
forms of opioid-dependence treatment without analge-
sic properties, and 85% of heroin users believed their 
chronic pain contributed to their heroin use. 
All participants had previously tried various rem-
edies for managing their chronic pain, involving tradi-
tional pharmacologic, illicit, and CAM treatments with 
varying levels of relief (Table 3). Almost all, 92%, used 
illicit opioids and found them to be at least somewhat 
helpful in alleviating their pain. Overall, opioids, in-
cluding heroin, were reported as the most helpful medi-
cation treatment. The most common complementary 
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anxiety scores reflected suggestive to full anxiety. For 
both depression and anxiety, TAU had slightly higher 
levels from Baseline through Week 12. Anxiety and 
depression scores remained stable and did not change 
throughout the trial. 
patient global impression of Change (pgiC)(32) 
The PGIC measure presented the greatest signifi-
cant difference between the massage and TAU groups. 
The groups began the study with no change in PGIC. 
At both Weeks 4 and 8, massage patients reported 
statistically significant improvement over TAU for 
minimally improved and much improved, p = .005 
and p < .001, respectively (Figure 3). This difference 
was not sustained at the Week 12 follow-up visit, 
p = .95, where massage participants reported higher 
levels of feeling minimally to much worse than TAU. 
Adverse events
There were no adverse events related to the inter-
vention reported during the trial. 
treatment was stretching (75%) and the majority of 
those found it to be at least somewhat helpful. 
numeric rating scale (nrs)(28)
Pain scores were not associated with anatomic site 
on the body, type of chronic pain, or initial severity of 
pain. For the three NRS pain measures — pain in last 
24 hours, average pain in last week, and worst pain in 
last week (Figure 1) — massage participants reported 
lower pain scores relative to the TAU group for Weeks 
4 and 8 and no difference at Week 12. For both TAU 
and massage, the mean of their average pain scores 
for all three measures of pain were lower at Week 12 
than at Baseline. The Weeks 4 and 8 improvements in 
the massage group did not attain clinical or statistical 
significance, except for worst pain at Week 8.
hospital Anxiety and depression scale (hAds)(31)
Participants were consistently more anxious than 
depressed regardless of treatment group. Depression 
scores were in the suggestive group, 8–10, while 
Table 3. NRS Pain Score Changes Stratified by Group and Belief to be Pain-free
Group Baseline Week 8 Week 12
Baseline – Week 8 Baseline – Week 12
Difference % changea Difference % changea
Massage (Pain-free n = 8, Not Pain-free n = 19)
Average Pain 5.8 4.6 5.2 1.2 21 0.6 10
Pain-free 5.8 3.8 5.3  2.0b 35 0.5 9
Not Pain-free 5.8 5.0 5.2 0.9 15 0.6 11
Worst Pain 8.0 6.0 6.7  2.0b 25 1.3 16
Pain-free 8.0 4.6 6.5  3.4b 42 1.5 19
Not Pain-free 8.1 6.5 6.8 1.6 19 1.3 16
Pain last 24 hr 5.4 4.3 4.8 1.1 20 0.6 11
Pain-free 5.0 3.5 4.6 1.5 30 0.4 7
Not Pain-free 5.6 4.6 4.9 1.0 18 0.7 13
TAU (Pain-free n = 7, Not Pain-free n = 17)
Average Pain 5.8 5.3 5.2 0.5 9 0.6 18
Pain-free 5.1 4.7 5.0 0.5 9 0.1 3
Not Pain-free 6.0 5.5 5.6 0.5 8 0.4 7
Worst Pain 8.0 6.7 6.8 1.3 16 1.2 15
Pain-free 7.3 5.7 6.2 1.6 22 1.1 15
Not Pain-free 8.4 7.1 7.0 1.3 15 1.4 15
Pain last 24 hr 5.8 5.0 5.2 0.8 14 0.6 10
Pain-free 5.1 4.7 4.3 0.5 9 0.8 16
Not Pain-free 6.1 5.1 5.6 0.9 15 0.5 8
aAll percent changes were percent decreases
bClinically significant 2-point change
NRS = Numeric Rating Scale(27).
WIEST: MASSAGE IMPACT ON PAIN IN OPIOID-DEPENDENT PATIENTS
18
InternatIonal Journal of therapeutIc Massage and Bodywork—VoluMe 8, nuMBer 1, March 2015
WIEST: MASSAGE IMPACT ON PAIN IN OPIOID-DEPENDENT PATIENTS
FIgure 1. Mean pain scores for massage and TAU groups by week.
FIgure 2. Percent of participants responding (percent decrease in NRS pain scores) from Baseline to Week 8.
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for participants who could see themselves being pain-
free compared to 0.9 who could not. This difference 
is even wider for worst pain, 3.4-point change from 
Baseline to Week 8 compared to 1.6-point change. 
Figure 2 shows the percent of responders in the 
massage group who saw themselves as being able 
to be pain-free were greater than all other groups 
for each threshold (10%, 30%, and 50%). Statistical 
significant treatment effect was seen in the pain free 
group at the 30% threshold for average pain in Week 
8, z = -2.16, p = .03.
Missing data
All Baseline characteristics were collected in 
full. There were more missing data in the TAU (6%) 
group than the massage (3%) group. Overall study 
completion rates were 85% in massage and 75% in 
TAU. Missing an appointment was not significantly 
associated with group assignment; did not follow a 
monotone missing pattern (i.e., once missed a visit 
never to return). Given evidence from recent papers 
on the discussion of missing data in a longitudinal 
study,(48,49) multiple imputation was not performed, 
as the percentage of missing was low. 
disCussion
The opioid-dependent study population was largely 
homeless, unemployed, and averaged 12 years with 
chronic pain. The participants had tried a range of tra-
ditional, illicit, and CAM treatments for pain manage-
ment. Opioids, prescribed and illicit, were reported 
as being the most helpful in alleviating pain. The 
frequency of pain treatments ever tried was similar to 
the array reported by Barry and colleagues(50) in their 
Biologic Measures
For the biologic measures of blood pressure and 
urine drug screens, there were no changes observed 
from Baseline. Approximately 60% of participants 
(58.8%), consistently had urine drug screens nega-
tive for nonprescribed substances other than THC. 
Through Week 12, there was no difference in urine 
drug screen results between massage and TAU groups 
(p = .95). No improvements or differences in blood 
pressure between massage and TAU were observed 
as found in a previous meta-analysis.(47) Regardless 
of group assignment, there were no changes in the 
prescribed doses of methadone. Obesity (BMI ≥ 30) 
was not statistically associated with pain. Weight 
gain of 10 or more pounds was measured in 49% of 
participants, regardless of group assignment. 
pain-free
Slightly more than a quarter of participants (30%) 
felt that they could ever be pain-free, which was not 
statistically associated with Baseline level of pain. 
The reported ability to be pain-free or not pain-free 
did not change throughout the course of the trial re-
gardless of treatment group assignment. Participants 
reporting they could never be pain-free most com-
monly stated they would need to die, have a new body, 
or be rich to become pain-free. A significant decrease 
in NRS pain was reported in the pain-free subgroup of 
participants and this reached clinical significance — a 
change of two points — in the massage group when 
comparing Baseline to Week 8 (Table 3). Regardless 
of Baseline pain level, those who self-identified as 
having the potential to improve had larger decreases 
in pain. At Week 8 (Table 3) in the massage group, 
this magnitude of change for average pain was 2.0 
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trial had insufficient sample size to consider anatomic 
location, type or cause of pain, or the role of belief in 
being pain-free. Potential self-activation characteris-
tics of patients most amenable to massage interven-
tion should be identified at intake through screening.
(53,54) These data should be incorporated into future 
protocol development and revisions. 
Findings from this trial are preliminary. Given the 
low percentage of participants who felt they had the 
potential to be pain-free, future nonpharmacologic 
treatments for pain in addiction patients may wish 
to target approaches which incorporate a patient’s 
activation or self-efficacy involvement in treatment. 
In this high-risk and low income population, massage 
did not contribute to overall clinically significant 
improved pain levels, quality of life measures, or 
treatment outcomes; rather, it was limited to a small, 
more empowered, subgroup of participants. 
ConClusion
In this population of substance abuse patients 
with chronic pain, clinically significant improvement 
in pain was not observed in the intervention group 
receiving eight weekly Swedish massage sessions. 
However, massage participants who felt they could 
be pain-free reported clinically significant reductions 
in pain and improved treatment satisfaction. Future 
nonpharmacologic pain research in marginalized 
substance-using populations may wish to consider 
some of the challenges and limitations faced in this 
project and include examination of the role of self-
efficacy/activation in patients’ beliefs of their pain. 
Targeted treatment plans may allow providers to focus 
on the role of self-efficacy, potentially resulting in 
better coping methods, chronic pain management, 
and improved treatment outcomes. 
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study of methadone patients. For the primary outcome 
measure of pain intensity, the massage group reported 
greater improvements in pain. However, these only 
reached clinical significance for worst pain at Week 
8. Assessing participants’ self-activation may be a 
valuable tool for determining readiness to accept and 
engage in treatment interventions. Although factors, 
such as self-activation, are known to moderate the 
relationship between beliefs and health behaviors, 
the mechanisms underlying these effects are unclear.
(51) The subgroup self-identified as pain-free reported 
the greatest clinically significant improvements in all 
pain measures. There was no durability of treatment 
effect, as improvements in pain observed in the pain-
free subgroup were extinguished by Week 12. 
There were no changes in anxiety or depression 
levels for the massage and TAU groups. One likely 
explanation is the extreme marginalization of this 
patient population. A once-a-week massage treat-
ment which has an ameliorative effect on depression 
in some patient populations,(22,23) may be unlikely 
to reduce anxiety or depression in a group of largely 
unemployed, marginalized patients early in substance 
use recovery. 
Consistently, improvements in pain scores are 
associated with positive changes in patient’s Global 
Impression of Change (PGIC),(52) but this concor-
dance was not found in this study. Overall there were 
no clinically significant improvements in the three 
NRS pain scores relative to the TAU or to Baseline 
measures; however, participants reported statistically 
significant improvements in PGIC values relative to 
Baseline for Weeks 4 and 8. At Week 12, the posi-
tive effect was diminished and massage participants 
reported the highest levels of being much worse or 
minimally worse. Review of participant satisfaction 
surveys suggests that this was due to terminating the 
massages which they had come to appreciate for pain 
management. 
Overall, 49% of the study population gained 10 
or more pounds in the period from initial treatment 
intake to the Week 12 visit, a period of approximately 
six months. There were no differences in BMI chang-
es between the massage or TAU groups and BMI 
scores were not associated with pain scores. Given 
the high nutritional risk at Baseline and subsequent 
significant weight gain over six months, implemen-
tation of targeted nutritional counseling throughout 
treatment seems appropriate. 
There are several important limitations to this fea-
sibility trial, such as small sample size, absence of a 
true placebo, variation in types of chronic pain, and 
restriction to one massage type. Based on input from 
the study LMTs, future work should modify the Swed-
ish massage protocol through expansion of massage 
scope and inclusion of other techniques. Appropriate 
participants may be patients with pain in a specific 
anatomic location (e.g., lower back) or chronic pain 
of a specific type (e.g., fibromyalgia). The current 
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Trunk: 4 min
● Circular kneading clockwise around abdomen 
through the drape and friction up along sternum 
through the drape (1 min)
● Effleurage upper pectoral area to spread oil, fol-
lowed by petrissage and friction to upper pectoral 
area (1 min)
● Effleurage to posterior neck to spread oil; petris-
sage and friction along left side of neck from C1 
to occiput (1 min)
● Petrissage and friction along right side of neck 
from C1 to occiput (1 min)
Turning participant: 1 min
● Therapist holds top sheet while participant turns 
over into face-down (prone) position, with head 
and face in face cradle; participant has option of 
having pillow under the knees (1 min)
Back: 10 min 
● Undrape back
● Effleurage to entire back from sacrum to occiput 
to spread oil (1 min)
● Petrissage to right side of back from sacrum to 
shoulder joint (1 min)
● Cross-fiber friction along left erector spinae 
muscles from sacrum to occiput (1 min)
● Mobilization of scapula with friction to medial and 
lateral border (1 min)
● Effleurage to entire back from sacrum to occiput 
(1 min)
● Petrissage to left side of back from sacrum to 
shoulder joint (1 min)
● Cross-fiber friction along right erector spinae 
muscles from sacrum to occiput (1 min)
● Mobilization of scapula with friction to medial and 
lateral border (1 min)
● Effleurage and petrissage to posterior neck (1 min)
● Effleurage to entire back from sacrum to occiput 
(1 min); redrape back
Left lower extremity: 6 min
● Undrape lower extremity 
● Effleurage to entire posterior, medial, and lateral 
lower extremity (1 min)
● Petrissage to posterior, medial, and lateral thigh 
(1 min)
● Friction to ITB (1 min)
● Effleurage to entire posterior, medial, and lateral 
lower extremity (1 min)
● Petrissage to posterior, medial, and lateral leg (1 min)
● Friction around ankle and milking of foot followed 
by effleurage to entire posterior medial and lateral 
lower extremity (1 min); redrape lower extremity
Right lower extremity: 6 min
● Undrape lower extremity 
● Effleurage to entire posterior, medial, and lateral 
lower extremity (1 min)
AppendiCes
Appendix A: the Massage protocol 
50-minute swedish Massage protocol
Right upper extremity: 3 min 
● Undrape extremity
● Effleurage to entire upper extremity to spread oil 
(1 min)
● Petrissage to upper arm followed by effleurage to 
entire upper extremity (1 min)
● Petrissage to forearm, hand and fingers followed 
by effleurage to entire upper extremity (1 min)
● Redrape upper extremity
Left upper extremity: 3 min 
● Undrape extremity 
● Effleurage to entire upper extremity to spread oil 
(1 min)
● Petrissage to upper arm followed by effleurage to 
entire upper extremity (1 min)
● Petrissage to forearm, hand, and fingers followed 
by effleurage to entire upper extremity (1 min) 
● Redrape upper extremity
Left lower extremity: 7 min
● Undrape extremity
● Effleurage to entire anterior, medial, and lateral 
lower extremity to spread oil (1 min)
● Petrissage to front of thigh (1 min)
● Effleurage entire anterior and lateral lower extremity 
and petrissage and friction around patella (30 sec)
● Petrissage and friction to anterior, medial, and 
lateral leg (1 min 30 sec)
● Effleurage entire lower extremity and petrissage 
and friction around ankle joint (30 sec)
● Petrissage, friction and milking to foot (1 min 30 sec)
● Effleurage to entire anterior, medial, and lateral 
lower extremity, and redrape; cupping tapotement 
to entire lower extremity with vibration around 
kneecap (1 min)
Right lower extremity: 7 min
● Undrape extremity 
● Effleurage to entire anterior, medial and lateral 
lower extremity to spread oil (1 min)
● Petrissage to front of thigh (1 min)
● Effleurage entire anterior and lateral lower extremity 
and petrissage and friction around patella (30 sec)
● Petrissage and friction to anterior, medial, and 
lateral leg (1 min 30 sec)
● Effleurage entire lower extremity and petrissage 
and friction around ankle joint (30 sec)
● Petrissage, friction and milking to foot (1 min 30 sec)
● Effleurage to entire anterior, medial, and lateral 
lower extremity, and redrape; cupping tapotement 
to entire lower extremity with vibration around 
kneecap (1 min)
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● Cupping tapotement to left posterior lower extrem-
ity from buttocks to foot (1 min)
● Cupping tapotement to right posterior lower ex-
tremity from buttocks to foot (1 min) 
Therapist informs participant that the session is 
over, and instructs the participant to get off the table 
and get dressed after therapist leaves the room. 
● Petrissage to posterior, medial, and lateral thigh 
(1 min)
● Friction to ITB (1 min) 
● Effleurage to entire posterior, medial, and lateral 
lower extremity (1 min)
● Petrissage to posterior, medial, and lateral leg (1 min)
● Friction around ankle and milking of foot followed 
by effleurage to entire posterior medial and lateral 
lower extremity (1 min); redrape lower extremity
Finishing strokes: 3 min
● Soft fist beating, cupping, and hacking tapotement 
to entire back (1 min)
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Appendix B: recruitment flow Chart
Initially screened eligible (n=80) 
Active recruitment = 5/1/11-2/29/12 
Not eligible (n=18) due to: 
 Medical condition (n=7) 
 Pregnant (n=6) 
 Incarcerated (n=1) 
 Other (n=4) 
Eligible participants (n=62) 
 Did not respond to recruitment (n=7) 
 Refused (n=3) 
Randomized (N=52) 
(52/62=84% of eligible participants    
randomized) 
One participant withdrew      
consent (n=51) 
 
MASSAGE plus TAU (n-27) 
85% completed all visits 
96% completed 90% of visits 
 
TAU only (n=24) 
75% completed all visits 
83% completed 90% of visits 
TAU = Treatment as usual 
